Elmira Khabusheva to Humans
This is a "connection" page, showing publications Elmira Khabusheva has written about Humans.
Connection Strength
0.047
-
Can Ruxolitinib Crash TET2- and IDH2-Driven Clonal Hematopoiesis? Cancer Discov. 2024 Oct 04; 14(10):1768-1770.
Score: 0.025
-
MGL S3 Chimeric Enzyme Drives Apoptotic Death of EGFR-Dependent Cancer Cells through ERK Downregulation. Int J Mol Sci. 2022 Oct 24; 23(21).
Score: 0.006
-
Subtype of Neuroblastoma Cells with High KIT Expression Are Dependent on KIT and Its Knockdown Induces Compensatory Activation of Pro-Survival Signaling. Int J Mol Sci. 2022 Jul 13; 23(14).
Score: 0.005
-
Identification of cell type-specific correlations between ERK activity and cell viability upon treatment with ERK1/2 inhibitors. J Biol Chem. 2022 08; 298(8):102226.
Score: 0.005
-
Enhancer RNA AL928768.3 from the IGH Locus Regulates MYC Expression and Controls the Proliferation and Chemoresistance of Burkitt Lymphoma Cells with IGH/MYC Translocation. Int J Mol Sci. 2022 Apr 21; 23(9).
Score: 0.005